Omnicell, Inc. (OMCL) Stock Price & Analysis
Omnicell, Inc. (OMCL) closed at USD 35.95 on Thursday, October 15, 2026, up 1.58% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 35.39; the Oct 15, 2026 session ranged USD 35.23–36.23 on volume of 392,997 shares. Market capitalization is $1.63B, with a 52-week range of USD 29.09–55 (NMS). Source: Nexqual, retrieved October 16, 2026 at 05:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/OMCL.md
Key facts (OMCL)
- Last four reported quarters (through Jun 30, 2026): revenue $1.25B, net income $39.1M (3.1% margin), free cash flow $143M (SEC filings).
- Valuation: P/E 41.8x (avg 593.9x at the last 2 fiscal year-ends).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (8 analysts), mean target USD 57.86 (range 45–70).
- Total return with dividends: 1Y +18.6% vs S&P 500 +18.1%; 5Y -77.2% vs S&P 500 +85.1%.
- Next earnings: 2026-10-29, EPS estimate USD 0.42, revenue estimate $304M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (OMCL)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.13B | $1.30B | $1.15B | $1.11B | $1.18B | $1.25B |
| Gross profit | $555M | $589M | $497M | $471M | $503M | — |
| Operating income | $89.5M | -$2.3M | -$34.9M | $337K | $5.2M | $58.0M |
| Net income | $77.8M | $5.6M | -$20.4M | $12.5M | $2.1M | $39.1M |
| EPS (diluted) | $1.62 | $0.12 | -$0.45 | $0.27 | $0.04 | — |
| Free cash flow | $203M | $30.2M | $140M | $151M | $86.9M | $143M |
| Gross margin | 49.0% | 45.4% | 43.3% | 42.3% | 42.5% | — |
| Operating margin | 7.9% | -0.2% | -3.0% | 0.0% | 0.4% | 4.6% |
| Net margin | 6.9% | 0.4% | -1.8% | 1.1% | 0.2% | 3.1% |
| Revenue growth | +26.9% | +14.5% | -11.5% | -3.0% | +6.5% | — |
| Cash + short-term investments | $349M | $330M | $468M | $369M | $197M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (OMCL)
P/E 41.8x · P/S 1.3x · P/FCF 11.5x · P/B 1.3x · FCF yield 8.72% · Earnings yield 2.39%
P/E at fiscal year-ends: Dec 2025 1023.5x, Dec 2024 164.3x.
Analysts (OMCL)
Consensus Buy (mean 2.00 on a 1–5 scale), 8 analysts; mean target USD 57.86 (low 45, high 70).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-03 | Piper Sandler | Target lowered | Overweight | $55 → $45 |
| 2026-07-31 | Wells Fargo | Target lowered | Overweight | $55 → $50 |
| 2026-07-31 | Keybanc | Target lowered | Overweight | $70 → $65 |
Total return (dividends reinvested) (OMCL)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +18.6% | -77.2% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +18.7% | -25.6% |
| Volatility (annualized) | 50.1% | 48.5% |
| Max drawdown | -37.3% (Jan 2026→Sep 2026) | -85.9% (Nov 2021→May 2025) |
Key Statistics (as of October 16, 2026 at 05:21 UTC)
| Price | USD 35.95 |
|---|---|
| Change | ▲ 1.58% (up) |
| Previous Close | USD 35.39 |
| Open | USD 35.45 |
| Day Range | USD 35.23 – 36.23 |
| 52-Week Range | USD 29.09 – 55 |
| Volume | 392,997 shares |
| Market Cap | $1.63B |
| Exchange | NMS |
Technical Analysis (OMCL)
Nexqual's technical model rates OMCL "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 16, 2026 at 05:21 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.6 (neutral) |
| vs SMA50 | Above (USD 34.63) |
| MACD | 0.45 (positive) |
Analyst Ratings (OMCL)
Wall Street analysts rate OMCL "Buy" based on 8 analysts, with a mean price target of USD 57.86 (range USD 45–70), per Nexqual as of October 16, 2026 at 05:21 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 57.86 |
| High Target | USD 70 |
| Low Target | USD 45 |
| Buy / Hold / Sell | 7 / 1 / 0 |
Earnings (OMCL)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0.42 |
| Revenue Estimate | $304.47M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.94 vs est 0.47 ▲ beat |
| 2026-03-31 | USD 0.55 vs est 0.33 ▲ beat |
| 2025-12-31 | USD 0.4 vs est 0.5 ▼ miss |
| 2025-09-30 | USD 0.51 vs est 0.36 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financials & Fundamentals (OMCL)
| Total Revenue | $1.25B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +7.50% |
| Gross Margin | +44.01% |
| Operating Margin | +5.91% |
| Profit Margin | +3.14% |
| ROE | +3.06% |
| Debt / Equity | 0.15 |
| Current Ratio | 1.64 |
| Total Cash | $292.16M |
| Total Debt | $200.00M |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $86.89M (7.3% of revenue) |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Financial Health Score (OMCL)
Nexqual rates Omnicell, Inc.'s overall financial health "Solid" across five dimensions, as of October 16, 2026 at 05:21 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 6% |
| Balance Sheet | Strong — $292M cash vs $200M debt, net cash position |
| Cash Flow | Solid — FCF $87M (FY ended Dec 2025, 10-K), 7% margin |
| Efficiency | Weak — ROE 3%, ROA 1.5% |
Ownership (OMCL)
| Insider Ownership | +2.15% |
|---|---|
| Institutional Ownership | +108.42% |
| Shares Outstanding | 45.48M |
| Float | 44.38M |
| Short % of Float | +9.68% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Leadership (OMCL)
Omnicell, Inc. is led by Randall A. Lipps (age 68), Founder, Executive Chairman & CEO, per Nexqual as of October 16, 2026 at 05:21 UTC.
| Founder, Executive Chairman & CEO | Randall A. Lipps (age 68) |
|---|---|
| President & COO | Nnamdi N. Njoku (age 48) |
| Executive VP & CFO | H. Baird Radford (age 55) |
| Senior VP & CTO | Perry A. Genova |
| Vice President of Investor Relations | David Unger |
Major Backers & Investors (OMCL)
Notable institutional backers of Omnicell, Inc. include Wellington Management, Millennium Management, Nomura Asset Management International Inc, according to Nexqual as of October 16, 2026 at 05:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wellington Management | 5.94% |
| Millennium Management | 3.81% |
| Nomura Asset Management International Inc | 3.53% |
| Delaware Group Equity Funds V-Nomura Small Cap Core Fund | 1.77% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 25.26% |
| Vanguard Group | 18.98% |
| Dimensional Fund Advisors | 5.39% |
| State Street | 4.59% |
| Geode Capital | 2.68% |
| Nuveen | 2.26% |
Source: Nexqual, October 16, 2026 at 05:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CERT | Certara, Inc. | USD 9.66 | ▲ 0.63% |
| SDGR | Schrodinger, Inc. | USD 25.48 | ▼ 1.58% |
| GDRX | GoodRx Holdings, Inc. | USD 3.51 | ▲ 1.59% |
| OMDA | Omada Health, Inc. | USD 18.67 | ▲ 2.02% |
| TDOC | Teladoc Health, Inc. | USD 5.97 | ▼ 0.5% |
| HSTM | HealthStream, Inc. | USD 33.75 | ▲ 0% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt